Kalshi has reportedly filed to certify perpetual futures contracts for XRP, Solana, Dogecoin, and other altcoins in the U.S., following its recent Commodity Futures Trading Commission (CFTC) approval for Bitcoin perpetual futures. This move aims to meet rising demand for regulated crypto derivatives and would expand Kalshi's offerings beyond Bitcoin. The filings are still pending regulatory approval, meaning these products are not yet confirmed for launch. If approved, U.S. traders could gain regulated access to trade XRP and other altcoin price exposure through perpetual futures without holding the actual tokens.
Entrada Therapeutics announced that an independent Data Monitoring Committee has recommended increasing the dose to 10 mg/kg for Cohort 2 in its ELEVATE-45-201 Phase 1/2 trial for Duchenne muscular dystrophy. This follows safety and pharmacokinetic r...
Herantis Pharma telah menerima tanggapan positif dari FDA AS mengenai desain studi Fase 2a untuk HER-096, kandidat utama mereka untuk pengobatan penyakit Parkinson. FDA tidak memiliki kekhawatiran mengenai informasi kimia, manufaktur, dan kontrol (CM...
ISTO announced the creation of the PNT Standards Consortium, a nonprofit group formed by Leidos, IS4S, and TRX Systems to advance open, interoperable standards for Positioning, Navigation, and Timing (PNT) systems. The consortium aims to provide long...
Cardinal Infrastructure Group announced the acquisition of Piedmont Pipe Construction, a leading wet utilities provider in North and South Carolina. This move expands Cardinal's wet utility capabilities in the growing Charlotte, NC market and integra...
YieldMax® has declared monthly distributions for its Target 12™ ETFs, aiming for a 12% annual income. The ETFs include BIGY, RNTY, and SOXY, each with varying distribution rates and risks such as price participation limits and liquidity concerns. Inv...
